[Mechanism of development of glucocorticoid-induced osteoporosis and its treatment. Intestinal calcium absorption and vitamin D metabolism in patients under glucocorticoid therapy and correction of secondary hyperparathyroidism].
D000328:Adult; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000378:metabolism*; D003095:Collagen Diseases / Q000188:drug therapy; D000242:Cyclic AMP / Q000032:analysis; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D007408:Intestinal Absorption / Q000187:drug effects*; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000139:chemically induced*; D010281:Parathyroid Hormone / Q000097:blood; D014237:Trichlormethiazide / Q000627:therapeutic use; D014807:Vitamin D / Q000378:metabolism*
D005938:Glucocorticoids; D010281:Parathyroid Hormone; D014807:Vitamin D; D000242:Cyclic AMP; D002117:Calcitriol; D014237:Trichlormethiazide; D002118:Calcium